CD8A and neoplasm: This process acts as a cascade expanding the array of antigens that the immune system employs to target the tumor: lysis of cancer cells by CD8+ T lymphocytes through the recognition of an initial peptide permits DCs to obtain access to the dead cells’ cytosolic components.